Clinical Trials Directory

Trials / Completed

CompletedNCT07190105

Vagal Approaches on Long COVID-19

Impact of Vagal Approaches on Symptomatology in Long COVID Participants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
546 (actual)
Sponsor
Leidos Life Sciences · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore whether two general wellness products, alone or combined, can support individuals experiencing Long COVID symptoms. Both wellness products stimulate the vagus nerve - a nerve that helps regulate stress, relaxation, mood, breathing, heart rate, inflammation, and digestion. The investigators will use a Fitbit to track participants' health measurements including, but not limited to, activity, heart rate, and heart rate variability, and participants will be asked to complete surveys about their experience. This information will be collected into a repository where participants can share their experiences with Long COVID symptoms.

Conditions

Interventions

TypeNameDescription
OTHERSonocea Sonic Augmentation Technology (SAT)The Sonocea Sonic Augmentation Technology (SAT) is a sound-based approach delivered via headphones through a smartphone application. The approach uses music soundscapes that have been standardized in format, intensity and duration.
OTHERTruvaga Electrical Vagus Nerve StimulatorThe Truvaga Electrical Vagus Nerve Stimulator is a general wellness product that sends gentle electrical signals through the skin to stimulate the vagus nerve on the neck.

Timeline

Start date
2025-10-27
Primary completion
2025-12-11
Completion
2025-12-11
First posted
2025-09-24
Last updated
2026-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07190105. Inclusion in this directory is not an endorsement.